Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMRNIB9)

Drug Name
CART-34 cells Drug Info
Indication
Disease Entry ICD 11 Status REF
Acute myeloid leukaemia 2A60 Phase 1 [1]
Myelodysplastic syndrome 2A37 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMRNIB9

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Preclinical Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Hematopoietic progenitor cell antigen CD34 (CD34)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AMR-001 DMGE8FK Heart failure BD10-BD13 Phase 2 [2]
CAR-T cells targeting CD34 DM3G0OP Acute myeloid leukaemia 2A60 Preclinical [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Hematopoietic progenitor cell antigen CD34 (CD34) TTZAVYN CD34_HUMAN CAR-T-Cell-Therapy [1]

References

1 ClinicalTrials.gov (NCT03291444) CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS
2 National Cancer Institute Drug Dictionary (drug id 743421).
3 ClinicalTrials.gov (NCT03473457) CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia